54gene

54gene Equalizing Precision Medicine

We are thrilled to announce that our CEO Abasi EneObong has been featured in TIME magazine.
The interview details how we...
11/08/2022

We are thrilled to announce that our CEO Abasi EneObong has been featured in TIME magazine.


The interview details how we’re fixing racial imbalance in health data, delves into the source of data dearth in global genomics research, and our mission to equalize precision medicine for all the world’s populations.


To read the full interview, click here: https://bit.ly/3djojs6

Join our VP, Clinical and Regulatory Affairs - Kemi Williams, tomorrow at the 2nd edition of Amgen and AfricaBio’s ‘Dive...
27/07/2022

Join our VP, Clinical and Regulatory Affairs - Kemi Williams, tomorrow at the 2nd edition of Amgen and AfricaBio’s ‘Diversity in Clinical Trials’ webinar series, as she provides valuable insight into precision medicine awareness, ethics and regulation, and health solutions aligned to Africa’s genomic diversity.

Click here to register for the event: https://bit.ly/3J7Tbrv

Wishing you and your families a joyful celebration
10/07/2022

Wishing you and your families a joyful celebration

On Tuesday, June 28, our CEO & Founder, Dr Abasi Ene-Obong will give  a talk based on his academic and commercial experi...
27/06/2022

On Tuesday, June 28, our CEO & Founder, Dr Abasi Ene-Obong will give a talk based on his academic and commercial experiences at his alma mater - Barts Cancer Institute, Queen Mary University of London. This virtual presentation will be held on Faculty of Medicine and Dentistry’s (FMD) Enterprise Day 2022.

The talk, titled “From Lab to the Boardroom: A Perspective”, seeks to provide inspiration and insight to the current postgraduate students on the academic and commercial opportunities available to them after school.

Other speakers at the engagement include Professor Andrew Livingston, and Professor Sir Mark Caulfield.

Registration for the event is free via the link below:
https://www.eventbrite.co.uk/e/fmd-enterprise-day-2022-tickets-353691228987

Cutting-edge innovation is the bedrock of our vision to equalize precision medicine for Africans and the global populati...
27/06/2022

Cutting-edge innovation is the bedrock of our vision to equalize precision medicine for Africans and the global populations.

Thank you Nigerian Healthcare Excellence AWARD 2022 for honouring us with the ‘Innovative Healthcare Service Provider of the Year’ award.

Cheers!

19/06/2022

To commemorate this year's World Sickle Cell Day (June 19), our Chief Operating Officer - Delali Attiogbe Attipoe discussed how sickle cell disease can be made more prominent in pharmaceutical research on Deutsche Welle, a leading German broadcasting network.

Delali also spoke about what is needed in the field of healthcare research to boost global efforts to fight the disease, and the importance of higher African genome representation in achieving better health outcomes for not only Africans, but also the global populations.

Visit the link below to watch the full interview:
https://www.youtube.com/watch?v=pLqCg1mRnqA

Here are some photo memories from the Human Hereditary and Health in Africa (H3Africa) consortium meeting our team atten...
16/06/2022

Here are some photo memories from the Human Hereditary and Health in Africa (H3Africa) consortium meeting our team attended earlier this month.

The event featured brilliant presentations on how Africa can become competitive in genomic sciences, establish and nurture effective collaborations among African researchers on the continent, and generate unique data that could be used to improve health outcomes for Africans and global populations.

Photo 1: (L to R) Philip Ikeme, Peter Fekkes, Adrienne Leussa, Prof Ambroise Wonkam (Professor, and Director, McKusick-Nathans Institute, and Department of Genetic Medicine, at The Johns Hopkins University, USA), Colm O'Dushlaine, Prof Charles Rotimi (director of the Centre for Genomics and Global Health within the NIH National Human Genome Research Institute at Bethesda, Maryland in the US. He’s also the founder of the African Society of Human Genetics and the driving force behind the Human Heredity and Health in Africa, or H3Africa, which he helped to establish ten years ago), Delali Attipoe, Dr Callistus Adewale Akinleye (Epidemiologist/Public Health Physician/Senior Lecturer at Osun state university, Nigeria), Aminu Yakubu, Jumi Popoola, Estelle Dogbo.

Photo 2: (L to R) Peter Fekkes, Colm O'Dushlaine, Dr. Segun Fatumo (Assistant Professor of Genetic Epidemiology and Bioinformatics at the MRC/UVRI Uganda and London School of Hygiene and Tropical Medicine (LSHTM) . He leads The African Computational Genomics (TACG) Research group), Jumi Popoola, Aminu Yakubu

Photo 3: (L to R) Xavier David (Genotyping sales specialist at Illumina), Adrienne Leussa, Rodolphe Vetchenou (Executive partner account manager at Illumina), Dr. Palmer Netongo (Assistant Professor of Biochemistry, University of Yaounde 1, Cameroon)

Our CEO and Founder Dr Abasi Ene-Obong will participate in 2 panel discussions at Viva Technology 2022 - a prominent sta...
15/06/2022

Our CEO and Founder Dr Abasi Ene-Obong will participate in 2 panel discussions at Viva Technology 2022 - a prominent startup and tech event that brings business leaders, startups, investors, researchers and innovators together to ignite positive change in the global economy.

The 1st panel will be held Thursday, June 16, and is titled ‘Ecosystem Support to Health Tech Entrepreneurs Scale”. Dr Abasi will be joined by Managing Director of Norrsken East Africa - Pascal Murasira, Chefaa Co-founder and COO - Dr Rasha Rady, and i'SUPPLY Founder and CEO - Ibrahim Emam. The panel will be moderated in VivaTech’s AfricaTech Lab by APHRODICE Mutangana, Deputy Chief Executive Officer and Chief Operations Officer, Digital Africa.

The 2nd panel conversation is titled “Tailored Care: Accelerating Personalized Medicine” where the participants will dive into a better understanding of the relationship between illness and people’s genetic markups, how treatments can increasingly be tailored to specific people, and what benefits these technical advancements unlock for doctors and patients.

The other panelists in the second conversation are Alizée Blanchin - Head of Strategy & Innovation Consulting, Hello Tomorrow, and Kalle Conneryd Lundgren - Chief Clinical Operations Officer, Kry

To join this assembly of major international players, and get a dose of inspiration from some of the biggest thinkers and leaders of their respective sectors, visit the link in bio / the link below for more information about VivaTech 2022.

Link - https://vivatechnology.com/

The recent announcement of the SEN-GENOME Genetics Research Study marks the commencement of a transformative era for gen...
08/06/2022

The recent announcement of the SEN-GENOME Genetics Research Study marks the commencement of a transformative era for genomics research in Africa.

To help dissect the impact a project of this magnitude will have on the future of genomics research and precision medicine in Africa, we had a brief conversation with our Senior Vice President, Growth - Estelle-Louis Dogbo and Senior Operations Manager, French West Africa - Dr Amadou Sall.

Here is an excerpt from the interview: “One of the biggest hurdles in genomics research is the population's perception and misunderstanding of medical research objectives. 54gene will ensure that participants of the study are well informed of the benefits of their involvement in such an important project as requested by our research operation processes, and ethics and governance policies.”

For access to the full interview, click here: https://bit.ly/3tkfC5P

We are observing this year's National Cancer Survivor Month (June) by sharing how precision medicine is contributing to ...
07/06/2022

We are observing this year's National Cancer Survivor Month (June) by sharing how precision medicine is contributing to the gradual increase of cancer survival rate, and the role our work in 54gene plays in supporting global efforts to improve healthcare for all.

Flip through the images to learn more.

31/05/2022

Here is an audio excerpt (in French) of the conversation between our Senior Vice President of Growth - Estelle-Louise Dogbo and Christina Okello from Radio France Internationale (RFI) about our SEN-GENOME research study in collaboration with the Academy of Sciences and Techniques The InterAcademy Partnership (IAP) from Senegal.

Estelle shared some thoughts on how this study, the first-of-its-kind in Francophone Africa, is a significant step in enabling Senegal to contribute to the advancement of Precision Medicine in the country, for the benefit of Africans and the global population.

She also outlined some of the aims of the study, such as how it will lead to further research on genetic variants causing Non-Communicable Diseases and Rare Diseases, while providing new insights for people of African descent in diaspora who wish to explore their ancestry.

Visit the link below to listen to Estelle’s full interview: https://lnkd.in/dQEGD6uA

And this link to read our official announcement about the landmark SEN-GENOME Genetics Research study - https://bit.ly/3LQk56W

-------

Voici un extrait audio (en français) de la conversation de notre Senior Vice President of Growth - Estelle-Louise Dogbo avec Christina Okello de Radio France Internationale (RFI) à propos de l'étude SEN-GENOME menée en collaboration avec L'Académie des Sciences et Techniques The InterAcademy Partnership (IAP) du Sénégal.

Estelle a partagé quelques réflexions sur la façon dont cette étude, la première du genre en Afrique francophone, est une étape importante pour permettre au Sénégal de contribuer à l'avancement de la médecine de précision (ou médecine génomique) dans le pays, au profit des Africains et de la population mondiale.

Elle a également décrit certains des objectifs de l'étude, tels que la manière dont elle conduira à de nouvelles recherches sur les variantes génétiques responsables des certaines Maladies Non Transmissibles et Maladies Rares, tout en offrant de nouvelles perspectives aux personnes de la diaspora africaine souhaitant explorer leur ascendance.

Visitez le lien ci-dessous pour écouter l'intégralité de l'interview d'Estelle: https://lnkd.in/dQEGD6uA

Et ce lien pour lire notre annonce officielle sur l'étude historique SEN-GENOME Genetics Research - https://bit.ly/3LQk56W

27/05/2022

World Diversity Day is set aside to hold thought-provoking conversations that support and enhance the importance of diversity, equity and inclusion (DEI) in all spheres of life.

Particularly in 54gene, a major aspect of our work is focused on increasing the representation of marginalized populations in genomics studies to equalize precision medicine for all people.

Considering how close to home this topic is for us, we sat down with VP, Human resources here at 54gene - Abi Bulus, who discusses the importance of having a diverse and people-focused ecosystem in our most recent blog post.

To learn more, click here: https://bit.ly/3NF4o3L

Address

Lagos

Opening Hours

Monday 09:00 - 18:00
Tuesday 09:00 - 18:00
Wednesday 09:00 - 18:00
Thursday 09:00 - 18:00
Friday 09:00 - 18:00

Alerts

Be the first to know and let us send you an email when 54gene posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to 54gene:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram